- Tytuł:
- Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States
- Autorzy:
- Temat:
-
primary glomerulonephritis
glomerular disease
end stage kidney disease
esrd
tarpeyo®
targeted-release budesonide
nefecon
Medicine (General)
R5-920
Therapeutics. Pharmacology
RM1-950 - Źródło:
- ClinicoEconomics and Outcomes Research, Vol Volume 15, Pp 213-226 (2023)
- Opis pliku:
- electronic resource
- Relacje:
- https://www.dovepress.com/cost-effectiveness-analysis-of-nefecon-versus-best-supportive-care-for-peer-reviewed-fulltext-article-CEOR; https://doaj.org/toc/1178-6981
- Dostęp URL:
- https://doaj.org/article/6e2f28e2681443f58955404792b76ea2  Link otwiera się w nowym oknie
Czasopismo naukowe